10-K Decoder · All companies

Tonix Pharmaceuticals Holding Corp.

TNXP · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue−$124M−$130M+4.6%
Operating income−$124M−$130M+4.6%
Net income−$124M−$130M+4.6%

Questions

What was Tonix Pharmaceuticals's revenue in FY2025?
−$124M in FY2025 (Fiscal year ended Dec 31, 2025), +4.6% vs −$130M a year earlier, per its 10-K filed Mar 2026.
Was Tonix Pharmaceuticals profitable in FY2025?
No: net income was −$124M and operating income −$124M in FY2025.